{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:46:56Z","timestamp":1781304416277,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T00:00:00Z","timestamp":1472860800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00467-016-3485-3","type":"journal-article","created":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T01:06:14Z","timestamp":1472864774000},"page":"283-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["International validation of a urinary biomarker panel for identification of active lupus nephritis in children"],"prefix":"10.1007","volume":"32","author":[{"given":"Eve Mary Dorothy","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Lyn","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Midgley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Goilav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Putterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Wahezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ekdawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Corkhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Ann","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen David","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Newland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Pilkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Tullus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael William","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,3]]},"reference":[{"issue":"7","key":"3485_CR1","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.34410","volume":"64","author":"L Watson","year":"2012","unstructured":"Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW (2012) Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum 64(7):2356\u20132365","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3485_CR2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0961203307087875","volume":"17","author":"LB Tucker","year":"2008","unstructured":"Tucker LB, Uribe AG, Fernandez M, Vila LM, McGwin G, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcon GS (2008) Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case\u2013control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17(4):314\u2013322","journal-title":"Lupus"},{"issue":"1","key":"3485_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rdc.2009.12.012","volume":"36","author":"R Mina","year":"2010","unstructured":"Mina R, Brunner HI (2010) Pediatric lupus-are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin N Am 36(1):53\u201380","journal-title":"Rheum Dis Clin N Am"},{"issue":"7","key":"3485_CR4","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/art.30350","volume":"63","author":"LT Hiraki","year":"2011","unstructured":"Hiraki LT, Lu B, Alexander SR, Shaykevich T, Alarcon GS, Solomon DH, Winkelmayer WC, Costenbader KH (2011) End-stage renal disease due to lupus nephritis among children in the US, 1995\u20132006. Arthritis Rheum 63(7):1988\u20131997. doi: 10.1002\/art.30350","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3485_CR5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/rheumatology\/34.9.866","volume":"34","author":"LB Tucker","year":"1995","unstructured":"Tucker LB, Menon S, Schaller JG, Isenberg DA (1995) Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34(9):866\u2013872","journal-title":"Br J Rheumatol"},{"issue":"4","key":"3485_CR6","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpeds.2007.09.019","volume":"152","author":"LT Hiraki","year":"2008","unstructured":"Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED (2008) Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr 152(4):550\u2013556","journal-title":"J Pediatr"},{"issue":"8","key":"3485_CR7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/ard.57.8.456","volume":"57","author":"J Font","year":"1998","unstructured":"Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S, Garcia-Carrasco M, Seisdedos L, Ingelmo M (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57(8):456\u2013459","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3485_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.1780360310","volume":"36","author":"KS Barron","year":"1993","unstructured":"Barron KS, Silverman ED, Gonzales J, Reveille JD (1993) Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 36(3):348\u2013354","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3485_CR9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0002-9343(78)90056-6","volume":"64","author":"AE Appel","year":"1978","unstructured":"Appel AE, Sablay LB, Golden RA, Barland P, Grayzel AI, Bank N (1978) The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study. Am J Med 64(2):274\u2013283","journal-title":"Am J Med"},{"issue":"12","key":"3485_CR10","first-page":"2635","volume":"29","author":"S Hagelberg","year":"2002","unstructured":"Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E (2002) Longterm followup of childhood lupus nephritis. J Rheumatol 29(12):2635\u20132642","journal-title":"J Rheumatol"},{"issue":"11","key":"3485_CR11","first-page":"819","volume":"49","author":"L Sun","year":"2011","unstructured":"Sun L, Xu H, Liu HM, Zhou LJ, Cao Q, Shen Q, Fang XY (2011) Long-term follow-up of 101 cases with pediatric lupus nephritis in a single center in Shanghai. Zhonghua Er Ke Za Zhi 49(11):819\u2013824","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"2","key":"3485_CR12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00467-006-0286-0","volume":"22","author":"BS Lee","year":"2007","unstructured":"Lee BS, Cho HY, Kim EJ, Kang HG, Ha IS, Cheong HI, Kim JG, Lee HS, Choi Y (2007) Clinical outcomes of childhood lupus nephritis: a single center\u2019s experience. Pediatr Nephrol 22(2):222\u2013231","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"3485_CR13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00467-007-0713-x","volume":"23","author":"N Ataei","year":"2008","unstructured":"Ataei N, Haydarpour M, Madani A, Esfahani ST, Hajizadeh N, Moradinejad MH, Gholmohammadi T, Arbabi S, Haddadi M (2008) Outcome of lupus nephritis in Iranian children: prognostic significance of certain features. Pediatr Nephrol 23(5):749\u2013755","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"3485_CR14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00330-002-1482-3","volume":"13","author":"A Preda","year":"2003","unstructured":"Preda A, Van Dijk LC, Van Oostaijen JA, Pattynama PM (2003) Complication rate and diagnostic yield of 515 consecutive ultrasound-guided biopsies of renal allografts and native kidneys using a 14-gauge Biopty gun. Eur Radiol 13(3):527\u2013530","journal-title":"Eur Radiol"},{"issue":"6","key":"3485_CR15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s004670050190","volume":"10","author":"KD Blake","year":"1996","unstructured":"Blake KD, Madden S, Taylor BW, Rees L (1996) Psychological and clinical effects of renal biopsy performed using sedation. Pediatr Nephrol 10(6):693\u2013695","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"3485_CR16","first-page":"1563","volume":"33","author":"M Faurschou","year":"2006","unstructured":"Faurschou M, Starklint H, Halberg P, Jacobsen S (2006) Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 33(8):1563\u20131569","journal-title":"J Rheumatol"},{"issue":"269","key":"3485_CR17","first-page":"779","volume":"72","author":"JM Esdaile","year":"1989","unstructured":"Esdaile JM, Levinton C, Federgreen W, Hayslett JP, Kashgarian M (1989) The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 72(269):779\u2013833","journal-title":"Q J Med"},{"issue":"11","key":"3485_CR18","first-page":"2046","volume":"21","author":"JM Esdaile","year":"1994","unstructured":"Esdaile JM, Joseph L, MacKenzie T, Kashgarian M, Hayslett JP (1994) The benefit of early treatment with immunosuppressive agents in lupus nephritis. J Rheumatol 21(11):2046\u20132051","journal-title":"J Rheumatol"},{"issue":"7","key":"3485_CR19","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/art.20345","volume":"50","author":"GG Illei","year":"2004","unstructured":"Illei GG, Tackey E, Lapteva L, Lipsky PE (2004) Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum 50(7):2048\u20132065","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3485_CR20","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar2816","volume":"11","author":"N Schwartz","year":"2009","unstructured":"Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C (2009) Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther 11(5):R143","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3485_CR21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0961203313484977","volume":"22","author":"B Abujam","year":"2013","unstructured":"Abujam B, Cheekatla S, Aggarwal A (2013) Urinary CXCL-10\/IP-10 and MCP-1 as markers to assess activity of lupus nephritis. Lupus 22(6):614\u2013623","journal-title":"Lupus"},{"issue":"1","key":"3485_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1756-185X.2012.01720.x","volume":"15","author":"HS Howe","year":"2012","unstructured":"Howe HS, Kong KO, Thong BY, Law WG, Chia FL, Lian TY, Lau TC, Chng HH, Leung BP (2012) Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis. Int J Rheum Dis 15(1):13\u201316","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"3485_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00467-007-0685-x","volume":"23","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, Wiers KM, Klein-Gitelman MS, Haines KA, Olson J, Onel KB, O\u2019Neil K, Passo MH, Singer NG, Tucker L, Ying J, Devarajan P, Brunner HI (2008) Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol 23(3):403\u2013412","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"3485_CR24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10157-010-0322-z","volume":"14","author":"MI Abd-Elkareem","year":"2010","unstructured":"Abd-Elkareem MI, Al Tamimy HM, Khamis OA, Abdellatif SS, Hussein MR (2010) Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings. Clin Exp Nephrol 14(6):548\u2013557","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"3485_CR25","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar3912","volume":"14","author":"S Singh","year":"2012","unstructured":"Singh S, Wu T, Xie C, Vanarsa K, Han J, Mahajan T, Oei HB, Ahn C, Zhou XJ, Putterman C, Saxena R, Mohan C (2012) Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis. Arthritis Res Ther 14(4):R164","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3485_CR26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00467-013-2668-4","volume":"29","author":"L Watson","year":"2013","unstructured":"Watson L, Tullus K, Pilkington C, Chesters C, Marks SD, Newland P, Jones CA, Beresford MW (2013) Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. Pediatr Nephrol 29(3):397\u2013405","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"3485_CR27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1203\/PDR.0b013e31819e4305","volume":"65","author":"M Suzuki","year":"2009","unstructured":"Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, Olson J, Onel K, O\u2019Neil KM, Silverman ED, Tucker L, Ying J, Devarajan P, Brunner HI (2009) Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 65(5):530\u2013536","journal-title":"Pediatr Res"},{"issue":"Suppl 11","key":"3485_CR28","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1002\/art.38494","volume":"66","author":"K Abulaban","year":"2014","unstructured":"Abulaban K, Brunner H, Nelson SL, Bennett M, Ying J, Song H, Kimmel P, Kusek J, Feldman H, Ramachandran V, Rovin BH (2014) Urine biomarkers role in predicting the future development of renal functional loss with lupus nephritis in children and adults. Arthritis Rheum 66[Suppl 11]:S111","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3485_CR29","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.34426","volume":"64","author":"HI Brunner","year":"2012","unstructured":"Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, Pendl J, Witte D, Ying J, Rovin BH, Devarajan P (2012) Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum 64(8):2687\u20132697","journal-title":"Arthritis Rheum"},{"key":"3485_CR30","doi-asserted-by":"crossref","unstructured":"Brunner HI, Bennett M, Abulaban K, Klein-Gitelman M, O\u2019Neil K, Tucker L, Ardoin S, Rouster-Stevens K, Onel K, Singer N, Eberhard BA, Jung L, Imundo L, Wright T, Witte D, Rovin B, Ying J, Devarajan P (2015) Development of a novel renal activity index of lupus nephritis in children & young adults. Arthritis Care Res (Hoboken) 68(7):1003\u20131011","DOI":"10.1002\/acr.22762"},{"issue":"3","key":"3485_CR31","first-page":"403","volume":"20","author":"Y Molad","year":"2002","unstructured":"Molad Y, Miroshnik E, Sulkes J, Pitlik S, Weinberger A, Monselise Y (2002) Urinary soluble VCAM-1 in systemic lupus erythematosus: a clinical marker for monitoring disease activity and damage. Clin Exp Rheumatol 20(3):403\u2013406","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"3485_CR32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/0961203311431249","volume":"21","author":"L Watson","year":"2012","unstructured":"Watson L, Midgley A, Pilkington C, Tullus K, Marks S, Holt R, Jones C, Beresford M (2012) Urinary monocyte chemoattractant protein 1 and alpha 1 acid glycoprotein as biomarkers of renal disease activity in juvenile-onset systemic lupus erythematosus. Lupus 21(5):496\u2013501","journal-title":"Lupus"},{"issue":"10","key":"3485_CR33","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.4049\/jimmunol.179.10.7166","volume":"179","author":"T Wu","year":"2007","unstructured":"Wu T, Xie C, Wang HW, Zhou XJ, Schwartz N, Calixto S, Mackay M, Aranow C, Putterman C, Mohan C (2007) Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol 179(10):7166\u20137175","journal-title":"J Immunol"},{"issue":"4","key":"3485_CR34","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1053\/j.ajkd.2015.04.011","volume":"66","author":"R Nee","year":"2015","unstructured":"Nee R, Martinez-Osorio J, Yuan CM, Little DJ, Watson MA, Agodoa L, Abbott KC (2015) Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE. Am J Kidney Dis 66(4):630\u2013637","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3485_CR35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaut.2006.12.003","volume":"27","author":"N Schwartz","year":"2006","unstructured":"Schwartz N, Su L, Burkly LC, Mackay M, Aranow C, Kollaros M, Michaelson JS, Rovin B, Putterman C (2006) Urinary TWEAK and the activity of lupus nephritis. J Autoimmun 27(4):242\u2013250","journal-title":"J Autoimmun"},{"issue":"9","key":"3485_CR36","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/rheumatology\/keh284","volume":"43","author":"SD Marks","year":"2004","unstructured":"Marks SD, Pilkington C, Woo P, Dillon MJ (2004) The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology 43(9):1186\u20131189","journal-title":"Rheumatology"},{"issue":"7","key":"3485_CR37","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","volume":"44","author":"DA Isenberg","year":"2005","unstructured":"Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, D\u2019Cruz D, Griffiths B, Khamashta M, Maddison P, McHugh N, Snaith M, Teh LS, Yee CS, Zoma A, Gordon C (2005) BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group\u2019s disease activity index for patients with systemic lupus erythematosus. Rheumatology 44(7):902\u2013906","journal-title":"Rheumatology"},{"issue":"11","key":"3485_CR38","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"3485_CR39","volume-title":"Medical statistics made easy 3","author":"M Harris","year":"2014","unstructured":"Harris M, Taylor G (2014) Medical statistics made easy 3, 3rd edn. Scion Publishing Limited, Banbury","edition":"3"},{"key":"3485_CR40","unstructured":"R Core Team (2013) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. Available at: http:\/\/www.r-project.org\/ . Accessed 31 Aug 2015"},{"issue":"5","key":"3485_CR41","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng AK (2007) Understanding diagnostic tests 3: Receiver operating characteristic curves. Acta Paediatr 96(5):644\u2013647","journal-title":"Acta Paediatr"},{"issue":"1","key":"3485_CR42","volume":"2","author":"M Dall\u2019Era","year":"2015","unstructured":"Dall\u2019Era M, Levesque V, Solomons N, Truman M, Wofsy D (2015) Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome. Lupus Sci Med 2(1), e000089","journal-title":"Lupus Sci Med"},{"issue":"5","key":"3485_CR43","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/rheumatology\/kep468","volume":"49","author":"T Rubinstein","year":"2010","unstructured":"Rubinstein T, Pitashny M, Levine B, Schwartz N, Schwartzman J, Weinstein E, Pego-Reigosa JM, Lu TY, Isenberg D, Rahman A, Putterman C (2010) Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology 49(5):960\u2013971","journal-title":"Rheumatology"},{"issue":"6","key":"3485_CR44","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3899\/jrheum.111470","volume":"39","author":"AN Kiani","year":"2012","unstructured":"Kiani AN, Wu T, Fang H, Zhou XJ, Ahn CW, Magder LS, Mohan C, Petri M (2012) Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis. J Rheumatol 39(6):1231\u20131237","journal-title":"J Rheumatol"},{"issue":"6","key":"3485_CR45","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/art.22594","volume":"56","author":"M Pitashny","year":"2007","unstructured":"Pitashny M, Schwartz N, Qing X, Hojaili B, Aranow C, Mackay M, Putterman C (2007) Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum 56(6):1894\u20131903","journal-title":"Arthritis Rheum"},{"key":"3485_CR46","first-page":"759313","volume":"2012","author":"CC Yang","year":"2012","unstructured":"Yang CC, Hsieh SC, Li KJ, Wu CH, Lu MC, Tsai CY, Yu CL (2012) Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus. J Biomed Biotechnol 2012:759313","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"3485_CR47","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.4049\/jimmunol.163.5.2883","volume":"163","author":"T Fournier","year":"1999","unstructured":"Fournier T, Bouach N, Delafosse C, Crestani B, Aubier M (1999) Inducible expression and regulation of the alpha 1-acid glycoprotein gene by alveolar macrophages: prostaglandin E2 and cyclic AMP act as new positive stimuli. J Immunol 163(5):2883\u20132890","journal-title":"J Immunol"},{"issue":"2","key":"3485_CR48","first-page":"530","volume":"276","author":"J Sorensson","year":"1999","unstructured":"Sorensson J, Matejka GL, Ohlson M, Haraldsson B (1999) Human endothelial cells produce orosomucoid, an important component of the capillary barrier. Am J Physiol 276(2):530\u2013534","journal-title":"Am J Physiol"},{"issue":"1","key":"3485_CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00916390","volume":"17","author":"T Nakamura","year":"1993","unstructured":"Nakamura T, Board PG, Matsushita K, Tanaka H, Matsuyama T, Matsuda T (1993) Alpha 1-acid glycoprotein expression in human leukocytes: possible correlation between alpha 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis. Inflammation 17(1):33\u201345","journal-title":"Inflammation"},{"issue":"2","key":"3485_CR50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/HJH.0000000000000019","volume":"32","author":"N Ohara","year":"2014","unstructured":"Ohara N, Hanyu O, Hirayama S, Nakagawa O, Aizawa Y, Ito S, Sone H (2014) Hypertension increases urinary excretion of immunoglobulin G, ceruloplasmin and transferrin in normoalbuminuric patients with type 2 diabetes mellitus. J Hypertens 32(2):432\u2013438","journal-title":"J Hypertens"},{"issue":"1\u20132","key":"3485_CR51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0167-4838(00)00161-8","volume":"1482","author":"Y Urade","year":"2000","unstructured":"Urade Y, Hayaishi O (2000) Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta 1482(1\u20132):259\u2013271","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"3485_CR52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000045937","volume":"87","author":"N Hirawa","year":"2001","unstructured":"Hirawa N, Uehara Y, Ikeda T, Gomi T, Hamano K, Totsuka Y, Yamakado M, Takagi M, Eguchi N, Oda H, Seiki K, Nakajima H, Urade Y (2001) Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus. Nephron 87(4):321\u2013327","journal-title":"Nephron"},{"issue":"13","key":"3485_CR53","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1177\/0961203310374485","volume":"19","author":"MH Otten","year":"2010","unstructured":"Otten MH, Cransberg K, van Rossum MA, Groothoff JW, Kist-van Holthe JE, Ten Cate R, Van Suijlekom-Smit LW (2010) Disease activity patterns in juvenile systemic lupus erythematosus and its relation to early aggressive treatment. Lupus 19(13):1550\u20131556","journal-title":"Lupus"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3485-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-016-3485-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3485-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-016-3485-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T23:18:42Z","timestamp":1692487122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-016-3485-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,3]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3485"],"URL":"https:\/\/doi.org\/10.1007\/s00467-016-3485-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,3]]}}}